Haisco Pharmaceutical Group Co., Ltd.

SZSE:002653.SZ

23.19 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q3
Revenue 922.017742.344953.1431,014.24746.054623.644918.523849.425685.336562.01862.049635.077548.078728.111954.439923.684862.789588.688951.031,117.5051,029.808838.9971,342.881893.476712.252478.056540.703477.449565.058272.951490.643277.768493.216173.98397.446261.851314.058239.099363.949315.881307.34223.425263.567272.981271.331184.458269209.195212.019111.856219.792127.262178.11279.264204.114128.584
Cost of Revenue 254.113234.851286.303297.17223.797169.579245.685286.008217.394170.19247.87241.497230.025224.032355.051277.555248.613182.013271.128391.012351.126334.976735.45309.386279.599164.722261.629232.478106.03157.647103.07375.396138.27954.128140.43985.401105.93767.638126.28786.21684.26769.68172.02779.51468.45448.70359.37152.44755.5136.98270.83138.98766.00625.12271.56540.364
Gross Profit 667.903507.493666.84717.071522.257454.065672.838563.418467.942391.82614.179393.58318.053504.079599.388646.128614.176406.675679.903726.493678.682504.021607.431584.09432.653313.334279.074244.971459.027215.304387.569202.371354.938119.852257.007176.449208.121171.461237.662229.665223.074153.744191.54193.467202.877135.755209.628156.747156.50974.874148.96188.275112.10654.142132.54988.221
Gross Profit Ratio 0.7240.6840.70.7070.70.7280.7330.6630.6830.6970.7120.620.580.6920.6280.70.7120.6910.7150.650.6590.6010.4520.6540.6070.6550.5160.5130.8120.7890.790.7290.720.6890.6470.6740.6630.7170.6530.7270.7260.6880.7270.7090.7480.7360.7790.7490.7380.6690.6780.6940.6290.6830.6490.686
Reseach & Development Expenses 126.84883.512170.537132.244117.96591.51170.47697.17494.29885.918150.60289.368101.63392.527187.332104.86262.03251.30799.04146.40247.61842.36299.86639.117103.67932.88123.53547.14196.0210127.13059.4390157.492078.10126.143088.591060.572050.446062.85000000000
General & Administrative Expenses -25.52490.735-164.28231.886-42.26886.964-156.965201.031-40.41572.467-172.688207.908-38.17189.019-156.864100.871-21.87562.874-112.01568.449-12.38546.142-76.97839.242-51.66778.851-137.00877.223-39.34670.214-141.7661.269-40.90672.017-148.31372.602-28.95845.596-138.25658.127-38.99551.47-105.1240.757-31.65446.323-64.6932.427-9.92729.138-44.20621.064-7.16817.615-28.37216.108
Selling & Marketing Expenses 322.588267.808342.82371.498259.413226.652354.222338.62245.955197.362292.654250.721178.926254.03332.847330.06366.662239.946446.746446.523464.988355.149390.228426.924274.12236.188195.365130.836302.59125.584236.7773.734152.46216.40571.26948.35128.84729.71580.60152.56753.30629.06252.12333.07435.06724.13754.75429.86329.49113.6767.57.4344.5967.1528.0914.229
SG&A 409.687358.119387.054603.384217.145313.616197.257539.651205.541269.829119.966458.63140.755343.048175.983430.932344.787302.82334.731514.972452.603401.29313.25466.165222.454315.03958.357208.059263.244195.79795.01135.004111.55688.423-77.044120.953-0.1175.312-57.655110.69414.31180.531-52.99773.8313.41370.461-9.93662.29119.56442.814-36.70728.498-2.57224.766-20.28220.338
Other Expenses -52.992-1.018-10.408-1.926-1.5314.398252.46-115.205115.937-2.0684.904-5.716-0.7650.061-6.05-1.231-1.646-0.419-3.9040.7440.8121.968-0.605-0.8580.1950.336-9.9411.558-6.8868.09370.6554.37974.9432.9132.5685.160.5852.7373.4233.58741.1991.99446.64115.99532.82515.74641.34315.64117.42860.60615.08631.6276.27430.07922.03-33.234
Operating Expenses 589.526442.649567.999554.808473.565409.524620.193521.62415.776353.678537.866432.234308.481433.066592.825449.747506.692266.013545.218566.708474.151452.806558.219432.373358.218245.055257.273158.528359.407199.802326.439139.082219.73289.61168.989124.036101.11778.475146.995114.605110.55783.49771.5177.29584.02973.72199.8264.88268.93543.01333.74530.02333.19625.07432.91721.809
Operating Income 78.37764.84398.841138.42935.3826.294280.39724.79934.01425.23473.438-46.28318.473466.629266.154192.187107.748132.709119.612163.758206.57556.8512.973161.78879.45669.74631.5684.201111.27238.92876.61380.031145.14346.198.26269.826125.253111.739103.619136.31126.38388.207136.331125.258128.74170.965116.566101.47595.11435.657116.79459.93580.79929.834101.92666.444
Operating Income Ratio 0.0850.0870.1040.1360.0470.0420.3050.0290.050.0450.085-0.0730.0340.6410.2790.2080.1250.2250.1260.1470.2010.0680.010.1810.1120.1460.0580.1760.1970.1430.1560.2880.2940.2650.2470.2670.3990.4670.2850.4320.4110.3950.5170.4590.4740.3850.4330.4850.4490.3190.5310.4710.4540.3760.4990.517
Total Other Income Expenses Net 26.59671.32132.67-1.926-1.531-0.7061.282-0.7392.523-0.8964.904-13.3458.136395.677253.541-5.425-1.382-8.372-18.9764.7172.8567.603-36.8449.2145.2171.802-0.003-0.814.73131.50386.26320.50684.69218.74612.45922.16418.82121.35416.25424.81955.02919.95460.01725.08141.97824.67744.60325.2524.96964.40215.62533.318.16330.84523.83828.939
Income Before Tax 104.973136.164131.511136.50333.84925.588281.67824.0636.53824.33878.341-51.99917.708466.69260.104190.956106.102132.29115.708164.502207.38758.81812.368160.9379.65270.08221.79785.632104.35247.004147.39483.796219.89848.989100.47774.577125.825114.341106.921139.879167.54690.201180.047141.254160.82786.71154.411117.115112.54396.263130.8491.56287.07359.912123.46995.35
Income Before Tax Ratio 0.1140.1830.1380.1350.0450.0410.3070.0280.0530.0430.091-0.0820.0320.6410.2730.2070.1230.2250.1220.1470.2010.070.0090.180.1120.1470.040.1790.1850.1720.30.3020.4460.2820.2530.2850.4010.4780.2940.4430.5450.4040.6830.5170.5930.470.5740.560.5310.8610.5950.7190.4890.7560.6050.742
Income Tax Expense 29.0855.46712.216.957-9.397-2.81-7.469-8.561-6.67-2.332.93-6.553-13.81710.59831.47628.59914.2413.93215.00220.7924.12811.645-12.6135.758-2.35214.6985.90510.83210.2762.6696.3149.8424.3296.9465.91511.72310.6114.81312.93614.96817.1718.93216.62212.53714.6925.7697.7369.8594.54115.13519.86114.74812.7939.6919.43915.132
Net Income 72.76191.95694.369125.66746.32628.749289.14733.22943.61926.20369.96-45.16933.006287.262233.881174.217100.143128.38110.698148.359185.01249.82330.067157.79785.59959.76524.27974.82194.09744.356141.09473.984195.58642.0694.56162.854115.21599.52893.985124.912150.37581.269163.425128.717146.13580.942146.674107.256108.00281.129110.97976.81474.2850.223104.03180.218
Net Income Ratio 0.0790.1240.0990.1240.0620.0460.3150.0390.0640.0470.081-0.0710.060.3950.2450.1890.1160.2180.1160.1330.180.0590.0220.1770.120.1250.0450.1570.1670.1630.2880.2660.3970.2420.2380.240.3670.4160.2580.3950.4890.3640.620.4720.5390.4390.5450.5130.5090.7250.5050.6040.4170.6340.510.624
EPS 0.0660.0830.0850.110.0420.0260.270.0250.0330.020.058-0.0430.0310.270.230.170.0940.120.10.140.190.050.0290.150.0860.060.0230.060.0850.040.130.070.190.040.090.060.10.090.090.120.150.080.150.120.130.070.140.10.0990.0740.10.0780.0770.0520.115.94
EPS Diluted 0.0660.0830.0850.110.0420.0260.270.0250.0330.020.058-0.0430.0310.270.230.170.0940.120.10.140.190.050.0290.150.0860.060.0230.060.0850.040.130.070.190.040.090.060.10.090.090.120.150.080.150.120.130.070.140.10.0990.0740.10.0780.0770.0520.115.94
EBITDA 139.415105.913149.933147.70445.11736.654296.36338.62852.00835.42192.956-43.5319.855472.004279.352203.759113.841139.724127.845168.812216.26964.0648.57159.67693.90271.97578.49496.45144.8167.832293.9264.856255.37530.514180.21353.093154.41592.594219.811115.392191.47870.106277.751116.988185.94362.033272.65191.86588.33131.862205.03358.253117.99729.068175.265.952
EBITDA Ratio 0.1510.1430.1570.1460.060.0590.3230.0450.0760.0630.108-0.0690.0360.6480.2930.2210.1320.2370.1340.1510.210.0760.0360.1790.1320.1510.1450.2020.2560.0290.5990.2330.5180.1750.4530.2030.4920.3870.6040.3650.6230.3141.0540.4290.6850.3361.0140.4390.4170.2850.9330.4580.6620.3670.8580.513